alexa New treatment concepts in diffuse large B-cell lymphomas (DLBL): chemothe-rapy and biological therapy.
Neurology

Neurology

Journal of Neurological Disorders

Author(s): Rodriguez J, Gutierrez A

Abstract Share this page

Abstract While CHOP has been the standard treatment for DLBL, the low cure rate of approximately 40\% implies that there is a need for improvement. Several hypotheses have been tested to optimize treatment. The Goldie and Coldman hypothesis sustains that drug resistance is a function of tumor burden and, accordingly, third generation regimens were designed. A randomized trial comparing CHOP with them showed no difference in the outcome. The myeloablative dose-intensity has become established as the best salvage therapy currently available for chemosensitive relapse of DLBL. However when tested as a frontline therapy clear results have not been obtained. The Norton and Simon hypothesis is based in Gompertzian kinetics whereby the growth rate of smaller tumors is higher. Thus, the dose-dense concept emerges, shortening the intervals between cycles and lowering tumor regrowth with CHOP-14 has recently been shown to improve the outcome in patients with DLBL. Addition of Rituximab-based immunotherapy is being tested in ongoing trials. Other approaches to optimize the treatment are based on a dynamic decision following early responses based on new imaging techniques. Finally, the analysis of tissue arrays and genomic profiling, which provide insights into the oncogenic pathways involved, is allowing the development of new targets.
This article was published in Rev Recent Clin Trials and referenced in Journal of Neurological Disorders

Relevant Expert PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords